New Key Statistics Module, Z-Score and F-Score
OTCPK:CLVLY Key Ratios
Market Cap $ M | 361.68 |
Enterprise Value $ M | 251.76 |
P/E(ttm) | 15.54 |
PE Ratio without NRI | 15.54 |
Forward PE Ratio | 15.84 |
Price/Book | 2.94 |
Price/Sales | 6.86 |
Price/Free Cash Flow | 19.31 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.07 |
Revenue (TTM) $ M | 58.00 |
EPS (TTM) $ | 0.47 |
Beneish M-Score | -2.25 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 31.30 |
y-y EBITDA Growth Rate % | 15.20 |
EV-to-EBIT | 6.86 |
EV-to-EBITDA | 6.72 |
PEG | 0.50 |
Shares Outstanding M | 50.06 |
Net Margin (%) | 40.41 |
Operating Margin % | 54.44 |
Pre-tax Margin (%) | 57.47 |
Quick Ratio | 8.39 |
Current Ratio | 8.81 |
ROA % (ttm) | 16.80 |
ROE % (ttm) | 19.57 |
ROIC % (ttm) | 98.82 |
Dividend Yield % | 0.47 |
Altman Z-Score | 14.70 |
CLVLY Number of Guru Trades
CLVLY Volume of Guru Trades
Gurus Latest Trades with OTCPK:CLVLY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CLVLY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Clinuvel Pharmaceuticals Ltd Insider Transactions
No Available Data
News about OTCPK:CLVLY
Total 0- 1